Japneet Kaur

Postdoctoral fellow

UAMS

Last publication 2025 Last refreshed 2026-05-22

postdoc

JKaur4@uams.edu

15 h-index 103 pubs 612 cited

Research Areas

Links

ORCID Lab Website

OverviewAI-generated summary

Japneet Kaur's research focuses on cellular senescence, aging, and bone biology, with investigations into osteocyte function and the therapeutic potential of senolytic agents. Her work examines the role of senescence in age-related conditions and disease progression, including in the context of cancer metastasis and diabetes.

Kaur has investigated the effects of zoledronic acid on senescence markers in vitro and in vivo. Her publications also explore the role of microRNAs in regulating osteoblast senescence and bone aging. She is a Co-Principal Investigator on a federal grant from the NIH for the development of a minimally invasive biomarker assay to detect delayed radiation injury, receiving $395,650 for this project.

Her research network includes extensive collaboration with researchers at the University of Arkansas for Medical Sciences, such as Hayley M. Sabol, Elena Ambrogini, Aric Anloague, and Olivia Reyes‐Castro, with whom she has co-authored numerous publications. Kaur has published over 100 works, with an h-index of 14 and over 580 citations.

Metrics

h-index: 15
Publications: 103
Citations: 612

Selected Publications

Targeting NOTCH3 to eradicate dormant and therapy-resistant multiple myeloma cells (2026)

DOI OpenAlex
Additional file 1 of Targeting NOTCH3 to eradicate dormant and therapy-resistant multiple myeloma cells (2026)

DOI OpenAlex
Targeting NOTCH3 to eradicate dormant and therapy-resistant multiple myeloma cells (2026)

DOI OpenAlex
Additional file 1 of Targeting NOTCH3 to eradicate dormant and therapy-resistant multiple myeloma cells (2026)

DOI OpenAlex
Targeting NOTCH3 to eradicate dormant and therapy-resistant multiple myeloma cells (2026)

DOI OpenAlex
Healing of lytic lesions and restoration of bone health in multiple myeloma through sclerostin inhibition (2025)

1 citation DOI OpenAlex
Ex Vivo Model Systems of Cancer-Bone Cell Interactions (2025)

1 citation DOI OpenAlex
A novel CCL3-HMGB1 signaling axis regulating osteocyte RANKL expression in multiple myeloma (2024)

8 citations DOI OpenAlex
Single-Cell Transcriptomic Analysis Identifies Senescent Osteocytes That Trigger Bone Destruction in Breast Cancer Metastasis (2024)

13 citations DOI OpenAlex
Senolytics deplete senescent osteocytes and improve bone health in metastatic breast cancer (2024)

DOI OpenAlex
Single-cell Transcriptome Analysis Identifies Senescent Osteocytes as Contributors to Bone Destruction in Breast Cancer Metastasis (2024)

3 citations DOI OpenAlex
A NOTCH3-CXCL12-driven myeloma-tumor niche signaling axis promotes chemoresistance in multiple myeloma (2024)

10 citations DOI OpenAlex